RARRES2 and metabolic dysfunction-associated steatotic liver disease: On basis of the previous data and our study, a future study comprising persons without and with NAFLD and careful matching for glucose tolerance status will be necessary to address the question whether the presence of NAFLD modifies the association between chemerin and insulin resistance.